The Pearson Lab integrates clinical expertise, mathematical modeling, high dimensional statistics, and basic tumor biology methods to investigate and propose new treatments for head and neck cancer.
University of Michigan
Ann Arbor, MI
Fellowship - Hematology/Oncology
2016
University of Michigan
Ann Arbor, MI
Postdoctoral Fellowship - Nor Lab (2013-2017)
2016
University of Michigan
Ann Arbor, MI
Residency - Internal Medicine
2012
University of Rochester
Rochester, NY
MD - Medicine
2010
University of Rochester
Rochester, NY
PhD - Statistics
2009
Cornell University
Ithaca, NY
BS - Biometry and Statistics
2002
Slideflow: deep learning for digital histopathology with real-time whole-slide visualization.
Slideflow: deep learning for digital histopathology with real-time whole-slide visualization. BMC Bioinformatics. 2024 Mar 27; 25(1):134.
PMID: 38539070
Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model.
Dysregulated FGFR3 signaling alters the immune landscape in bladder cancer and presents therapeutic possibilities in an agent-based model. Front Immunol. 2024; 15:1358019.
PMID: 38515743
Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma.
Evolutionary dynamics of tipifarnib in HRAS mutated head and neck squamous cell carcinoma. Oral Oncol. 2024 Feb; 149:106688.
PMID: 38219706
Validation of the RSClin risk calculator in the National Cancer Data Base.
Validation of the RSClin risk calculator in the National Cancer Data Base. Cancer. 2024 Apr 15; 130(8):1210-1220.
PMID: 38146744
Mathematical model predicts tumor control patterns induced by fast and slow cytotoxic T lymphocyte killing mechanisms.
Mathematical model predicts tumor control patterns induced by fast and slow cytotoxic T lymphocyte killing mechanisms. Sci Rep. 2023 12 18; 13(1):22541.
PMID: 38110479
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010).
Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010). Clin Cancer Res. 2023 12 01; 29(23):4751-4759.
PMID: 37773077
The use of deep learning state-of-the-art architectures for oral epithelial dysplasia grading: A comparative appraisal.
The use of deep learning state-of-the-art architectures for oral epithelial dysplasia grading: A comparative appraisal. J Oral Pathol Med. 2023 Nov; 52(10):980-987.
PMID: 37712321
Deep learning applications in visual data for benign and malignant hematologic conditions: a systematic review and visual glossary.
Deep learning applications in visual data for benign and malignant hematologic conditions: a systematic review and visual glossary. Haematologica. 2023 08 01; 108(8):1993-2010.
PMID: 36700396
External Evaluation of a Mammography-based Deep Learning Model for Predicting Breast Cancer in an Ethnically Diverse Population.
External Evaluation of a Mammography-based Deep Learning Model for Predicting Breast Cancer in an Ethnically Diverse Population. Radiol Artif Intell. 2023 Nov; 5(6):e220299.
PMID: 38074785
Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study.
Deep learning-based subtyping of gastric cancer histology predicts clinical outcome: a multi-institutional retrospective study. Gastric Cancer. 2023 09; 26(5):708-720.
PMID: 37269416
Mark Roth Award
University of Michigan
2015
Chief Fellow in Hematology/Oncology
University of Michigan
2014 - 2015